Clinical Trials List
2022-09-01 - 2028-12-31
Phase III
Not yet recruiting3
Recruiting2
Suspended1
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chen-Yuan Lin 無
- Tzu-Ting Chen 無
- 王幸婷 無
- Ching-Chan Lin 無
- Yu-Min Liao 未分科
- 陳珈妤 無
- 王秀慈 無
- Ming-Yu Lien 無
- 鄭富銘 無
- Che-Hung Lin 無
- Chi-Ching Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- MING YAO 無
- 柯紀綸 無
- Sheng-chieh Chou 無
- 林耘曲 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Tsung-Jang Yeh 無
- 莊哲明 無
- Yi-Chang Liu 無
- Shih-Feng Cho 無
- Jeng-Shiun Du 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
70 participants
-
Global
1126 participants
